Marc Russo on running clinical trials in Australia and the INS
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
Release Date: 12/06/2021
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, host Dr. Ladan Jiracek sits down with Dr. , , whose lab uses intracranial brain recordings to study the biology of human cognition. Ignacio shares how cutting-edge neurotechnology like iEEG can reveal the neural dynamics behind decision-making, risk, memory, and brain states - and how those insights could unlock more targeted neuromodulation therapies for psychiatric disorders such as depression and anxiety. Top 3 Takeaways: Epilepsy patients undergoing seizure monitoring often have 100-200 electrodes implanted in their brains and may...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this solo episode of the Neural Implant Podcast, host Dr. Ladan Jiracek shares the story behind finally completing his PhD at the University of Florida - from the highs of passing his dissertation defense to the long, frustrating, and deeply technical journey of developing liquid crystal polymer (LCP)-based neural implants. I break down why LCP is so promising for long-term implantable devices, how delamination and bonding challenges became the core focus of his dissertation, and what it took to fabricate ultra-thin polymer electrodes approaching “biological invisibility.” I also...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, Paul Goode (Glucotrack) dives into the next wave of continuous glucose monitoring: an active, fully implantable CGM designed to deliver long-term, pacemaker-style reliability without external wearables. We discuss first-in-human progress, why implantables may change diabetes care at home, and a fascinating neural angle—how similar chemistry and form factors could be adapted to epidural glucose sensing and even paired with neural recording electrodes to capture metabolic and neural data together. If you care about closed-loop systems, chronic implants, or bridging...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, I speak with , Co-Founder and CSO of , an Italian neurotech company that is redefining the landscape of brain-computer interfaces. Corticale is pioneering a new generation of minimally invasive, CMOS-based neural implants that can record from thousands of neurons simultaneously—introducing their flagship technology, SiNAPS. Fabio walks us through how SiNAPS achieves single-cell resolution recordings via its 1024-electrode array, enabling high-fidelity access to both action potentials and local field potentials deep within cortical tissue. We...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, we sit down with , co-founder of , a groundbreaking medical technology company pioneering a new frontier in cancer treatment. By integrating neurotechnology, neurobiology, and machine learning, Coherence is building a platform that doesn't just fight cancer—it manages it in real time. Ben shares how Coherence is moving beyond the traditional "cut, burn, poison" model of oncology, and instead focusing on precision neuromodulation to monitor and control cancer progression—offering hope for 24/7 adaptive treatment with fewer side effects and...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we dive into the world of European intellectual property and medtech innovation with , a German and European Patent Attorney specializing in medical technology at . With a background in mechanical engineering, a Ph.D. in liver dialysis research, and a Master of Laws in European IP law, Christian brings a rare and powerful combination of technical, legal, and clinical insight. We explore how startups and investors should think about IP strategy in Europe, the impact of the new Unified Patent Court (UPC), the nuances between U.S. and EU patent landscapes, and how IP due...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special episode recorded after the workshop in Barcelona, I talk with and , two of the key organizers behind the . We dive into the vision behind this growing event, which brings together top researchers, engineers, clinicians, and entrepreneurs to explore the cutting edge of implantable medical devices. Nicolas and Antoni share insights on the evolution of AIMD technologies, the role of multidisciplinary collaboration, and how this annual workshop is shaping the next generation of innovators. We also touch on the challenges that startups face in the space—regulatory hurdles, IP...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we sit down with , Chief Business Officer of , to explore a groundbreaking approach to treating obstructive sleep apnea. Lunosa is developing a self-expanding, injectable neurostimulator that aims to replace invasive facial surgeries with a minimally invasive, high-impact solution — tapping into a $10 billion market. Chad also reflects on his time at , a pioneering neuromodulation company that saw both innovation and controversy. He shares insights from testifying against Stimwave’s former CEO, lessons learned from the company’s collapse, and how those experiences shape...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special on-location episode recorded in Leuven, Belgium, we sit down with the co-founders and technical leaders of — (CEO), (CTO), and (CSO). The team shares their journey developing a high-density, intracortical visual prosthesis aimed at restoring vision for the blind. From developing reliable insertion technology to achieving long-term biocompatibility in nonhuman primate models, ReVision Implant is at the forefront of neurotech innovation. Tune in to hear about their challenges, breakthroughs, and what’s next in the race to cure blindness through brain stimulation. This...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we speak with , CEO and co-founder of , a contract research organization helping Medtech and Biopharma startups slash months off their clinical timelines. With a focus on Latin America, Bioaccess enables early feasibility and first-in-human trials to be conducted faster, more affordably, and with high-quality data suitable for FDA and EU submissions. Julio shares how their global site network—built over 20 years—helps startups navigate regulatory hurdles, reduce costs, and de-risk innovation, all while improving patient lives in emerging markets. This episode is sponsored...
info_outlineDr Marc Russo is the president of the International Neuromodulation Society which is a nonprofit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation. Dr Russo runs a large multidisciplinary pain clinic in Australia. He has conducted a number of first-in-man studies of novel neuromodulation implants as well as designing unique leads and waveforms in spinal cord stimulation (SCS).
Top 3 Takeaways:
-
"Over more than a 20 year journey now we understand that these patients are best treated early rather than later. The best traded with as close to zero levels of opioids. And that doses higher than 40 milligrams per day, actually worsen outcomes for spinal cord stimulation,"
- "High dose exogenous opioid prescription can actually induce epigenetic change in the genome of a patient so that even if you remove something such as opioids after five years, the body doesn't return to its former expression of proteins and then maybe actually permanent changes that may have worse outcome."
- "What's in a book is not sacrosanct and that you need to not just blindly apply something that you read in a book and think that it was, descended from the tablets of Moses. You actually need to think of what are you doing and does that apply to this particular patient?"
0:45 "And do you want to introduce yourself?"
1:45 "What changes have you seen?"
3:45 "In bioelectronic medicine it's beneficial to have a combination of drugs and stimulation, but you're saying that's the opposite in pain? Is it something like a numbing effect or what's the justification that you found for this?"
5:45 "Is opioid something that lingers?"
7:30 "What are some other trends that you've noticed along your 20 years of working in the field?"
10:00 "So the stimulation is not something that's there forever that they're going to have to manage forever?"
11:30 What's it like running a clinical trials unit?
13:30 "What's the pain clinic, like what's the makeup of this and do hospitals send people to you or how does it work?"
15:15 "What would be the advantage of doing a clinical trial in Australia?"
16:30 "What's that process like, a clinical trial, and how long, how many patients are involved?"
19:00 "What would be a good clinical trial versus a bad clinical trial?"
24:00 "Is there anything that we didn't talk about that you wanted to mention?"